<rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:digibug.ugr.es:10481/109150">
      <dc:title>Safety and Preliminary Efficacy Findings from a Phase 2A Randomized, Double-Blind, Placebo-Controlled Trial of Setanaxib in Patients with Alport Syndrome SA-OR082</dc:title>
      <dc:creator>Esteban de la Rosa, Rafael José</dc:creator>
      <dc:date>2025-12-30T17:13:58Z</dc:date>
      <dc:date>2025-12-30T17:13:58Z</dc:date>
      <dc:date>2025-11</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>https://journals.lww.com/jasn/toc/2025/10001</dc:identifier>
      <dc:identifier>https://hdl.handle.net/10481/109150</dc:identifier>
      <dc:identifier>10.1681/ASN.20253w14s1fa</dc:identifier>
      <dc:identifier>10.1681/ASN.20253w14s1fa</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/</dc:rights>
      <dc:rights>embargoed access</dc:rights>
      <dc:rights>Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License</dc:rights>
   </ow:Publication>
</rdf:RDF>